Mark Henderson, Science Editor
Win VIP tickets
Stem cells with the capacity to form any type of tissue can be created from adult cells without destroying embryos, according to new research that suggests a way of sidestepping ethical controversy over the field.
Three separate teams of scientists have used genetic trickery to wind back the biological clock of mature skin cells from mice, to give them the unlimited potential of stem cells that are normally found only in embryos.
Though it remains uncertain whether the same technique would work in humans, the successes raise the prospect that powerful master cells for use in medicine and research could one day be created from adult bodies, removing any need to use embryos.
Scientists pointed out, however, that even if this does prove possible, research into embryonic stem cells (ESCs) will remain essential in the medium term to study how the reprogrammed cells work.
ESCs are found only in early-stage embryos, and are attractive to medical researchers as they are “plutipotent” — they can give rise to all the 200 or so tissue types found in the human body. The goal is to find ways of directing their growth so they can be used to provide replacement tissue for treating conditions such as Parkinson’s, diabetes and spinal paralysis.
While research using these cells is legal under licence in Britain, it is opposed by some religious groups as ESCs can be harvested only by destroying embryos.
The United States currently bans federal funding for such work, and President Bush is expected to veto a congressional bill seeking to lift the ban. A key vote on the issue is to be held in the US House of Representatives on Thrusday.
Stem cells are also found in adult tissue, but these are normally more limited in their potential than embryonic cells. In August last year, however, a team at Kyoto University in Japan reported that by activating four genes in mouse skin cells, it was possible to make stem cells that appeared as pluripotent as ESCs.
That work has now been repeated by three teams, at Kyoto University, and the Whitehead Institute and the Harvard Stem Cell Institute in Massachusetts, whose results are published in the journals Nature and Cell Stem Cell.
Each group has confirmed more fully than was previously possible that the reprogrammed cells, which began as a kind of skin cell known as fibroblasts, are fully pluripotent. When injected into mouse embryos, the cells contribute to every cell type, and are passed on to the next generation.
“These reprogrammed cells, by all criteria that we can apply, are indistinguishable from embryonic stem cells,” said Professor Rudolf Jaenisch, who led the Whitehead team. “Germline transmission is the final and definitive proof that these cells can do anything a traditionally derived embryonic stem cell can do.”
He cautioned, though, that while it was hoped that the same technique would work in humans, that would not be known for several years.
“All these results are preliminary and proof of principle. It will be a while before we know what can and can’t be done in humans. Human embryonic stem cells remain the gold standard for pluripotent cells, and it is a necessity to continue studying embryonic stem cells through traditional means.”
British stem cell experts agreed that while the work is encouraging, it does not mean that ESC research is unnecessary.
Robin Lovell-Badge, of the National Institute for Medical Research in London, said: “This work emphasises that if scientists reasonably up-to-date with current knowledge in the field can not guess what is just around the corner, then it is extremely unlikely that politicians will be able to do so – a good reason why regulation is better than laws based on prohibition.
“Clearly the work offers hope that similar methods can be applied to human somatic cells, obtained from patients, to turn them directly into ES-like cells for research and eventually for cell-based therapies. There is still a long way to go, however.”
Win a luxury weekend to Newcastle and its neighbour Gateshead, find out more here
Risk, resilience and embracing new technology
Industry sectors news at a glance. Interactive heatmap, video and podcast
Discover the power of collective thinking. Submit a solution and be in with a chance to win a Media Hub Home Entertainment System
The inside track on current trends in the charity, not for profit and social enterprise sectors
Everything the Business Traveller needs to know to make a better trip
Make the most of the summer and enter our fabulous photographic competition, you could win a £5000 holiday
Corsica is an island of beauty and contrast, an ideal holiday destination
Enjoy further reading from Travel to Fashion, Business to Sport, discover more
Shortcuts to help you find sections and articles
The clever way to lease a new car is with Car leasing made simple™
2009
per month on 36-month
Personal Contract Hire (PCH)
2008
42850
Car Insurance
£23,093 - £56,211
The Office for National Statistics
Newport, South Wales
£60,000
The Environment Agency
Bristol
Up to £90K
Boots
Midlands
OTE £85k
Credit Protection Association
Nationwide Opportunities
Completely London
Luxury Condo's in Manhattan with NYC views
The best new homes in Wimbledon?
Nationwide
Fabulous Cruise And Cruise & Stay Offers Including Virgin Atlantic Flights Prices Start From Only £699pp!
Last Minute Cruise And Cruise & Stay Offers. Med From £499pp, Caribbean From £699pp!
5 star quality at a 3 star price.
8 fabulous Canadian cities ...you won’t find cheaper
Contact our advertising team for advertising and sponsorship in Times Online, The Times and The Sunday Times, or place your advertisement.
Times Online Services: Dating | Jobs | Property Search | Used Cars | Holidays | Births, Marriages, Deaths | Subscriptions | E-paper
News International associated websites: Globrix Property Search | Property Finder | Milkround
Copyright 2009 Times Newspapers Ltd.
This service is provided on Times Newspapers' standard Terms and Conditions. Please read our Privacy Policy.To inquire about a licence to reproduce material from Times Online, The Times or The Sunday Times, click here.This website is published by a member of the News International Group. News International Limited, 1 Virginia St, London E98 1XY, is the holding company for the News International group and is registered in England No 81701. VAT number GB 243 8054 69.
I have a question regarding this issue that I hardly ever see discussed and wonder if anyone can provide more information to me. I have read that stem cells from embryos have a nasty side effect of unchecked tumor growth. This tumor growth kills and thus stem cells from embryos will never be viable for curing any illness or injury unless this can be overcome. Is this true and please nelighten me?
Thank you
Doug Deavers, Naples, FL, USA
This is huge news for regenerative medicine. However, I don't see why testing the suitability of this approach from mice to human should take YEARS if proper funding is given. There is no time to waste anymore here now that the ethical naysayers can be safely bypassed. Aging is such a debilitating and depressing issue FOR ALL OF US...
Remember, "In the long run, we all be dead" (J.M. Keynes)
Mel, Geneva Switzerland,
Stem Cell research is opposed by powerful groups not because of the ethics of killing embryos: that is a smokescreen.
The real reason for the opposition is the promise that these technologies will lead to CURES instead of TREATMENTS. Treatment is profitable. Cures are not. Corporations run the medical establishment and corporations exist to make money first and foremost.
The radical solution: Make health care non-profit across the board. Those who work in health care should be well compensated (especially nurses!) but beyond that, it should be illegal for health-care institutions (especially pharmaceutical manufacturers) to make more than a minimal profit.
The health care industry will survive, and become much more focused on health rather than profit, once the carpetbaggers are forced to move on to industries where profit does not come at the expense of the well-being of citizens.
Dave Lowerre, Fullerton, CA
Is is possible that the restrictions and bans on embryonic stem cell research have resulted in work leading to this breakthrough? Would such a breakthrouch have occured otherwise?
Use of adult stem cells made pluripotent is a way to prevent bodily rejection of the cells after implant, a major obstacle for the use of embryonic stem cells.
Frank, Merrimack, USA/New Hampshire